Caryn Domenici Belisle, RPh

The FDA approved Egrifta (tesamorelin) to treat lipodystrophy in HIV-infected patients.

Somaxon Pharmaceuticals' Silenor (doxepin HCl) has been FDA approved to treat long- or short-term insomnia in patients who have difficulty maintaining sleep.

Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant) was approved by the FDA for use in girls and women aged 10 to 25 for the prevention of cervical precancers and cervical cancer associated with oncogenic human papillomaviras types 16 and 18.